715220007: ténofovir alafénamide (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur de la transférase\Reverse transcriptase inhibitor\ténofovir alafénamide
\Substance categorized by disposition\agent antiviral\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\ténofovir alafénamide

\Drug or medicament (substance)\Anti-infective agent (substance)\agent antiviral\Substance with antiretroviral mechanism of action (substance)\Reverse transcriptase inhibitor\ténofovir alafénamide

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\Organic compound\...

\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic ester (substance)\ténofovir alafénamide

\Ester\Carboxylic ester (substance)\ténofovir alafénamide

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

32131000188113 ténofovir alafénamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

3301911010 Tenofovir alafenamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3301912015 Tenofovir alafenamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

746871000241111 ténofovir alafénamide (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
ténofovir alafénamide	est un(e) (attribut)	Reverse transcriptase inhibitor	true	Inferred relationship	Some
ténofovir alafénamide	est un(e) (attribut)	Tenofovir (substance)	false	Inferred relationship	Some
ténofovir alafénamide	Has disposition (attribute)	Reverse transcriptase inhibitor (disposition)	true	Inferred relationship	Some
ténofovir alafénamide	est un(e) (attribut)	Carboxylic ester (substance)	true	Inferred relationship	Some
ténofovir alafénamide	est un(e) (attribut)	inhibiteur de la transférase	false	Inferred relationship	Some
ténofovir alafénamide	Is modification of (attribute)	Tenofovir (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	a pour principe actif (attribut)	False	ténofovir alafénamide	Inferred relationship	Some	5
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	False	ténofovir alafénamide	Inferred relationship	Some	5
Tenofovir alafenamide fumarate (substance)	est un(e) (attribut)	False	ténofovir alafénamide	Inferred relationship	Some
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has precise active ingredient	True	ténofovir alafénamide	Inferred relationship	Some	4
Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide 10 mg oral tablet	Has basis of strength substance (attribute)	True	ténofovir alafénamide	Inferred relationship	Some	4
Tenofovir alafenamide fumarate (substance)	Is modification of (attribute)	True	ténofovir alafénamide	Inferred relationship	Some

Reference Sets

Canada English language reference set (foundation metadata concept)